You are visitor number
| The Fluoroquinolone
Toxicity Research Foundation
|
You are visitor number
|
  |
Fleroxacin | See downloads for: Adobe Files |
 |
|
|
|
|
All brand names are trademarks of their respected manufacturers.
The information being provided below is to be considered a quick
reference guide. For complete information please view the
complete package insert at
www.rxlist.com or by entering the drug name at
Drugs@FDA
Fleroxacin Brand Names Quinodis
Peripheral Neuropathy QUINOLONES MAY HAVE THE POTENTIAL TO PROLONG THE QTc INTERVAL OF THE ELECTROCARDIOGRAM IN SOME PATIENTS. DUE TO THE LACK OF CLINICAL EXPERIENCE, GATIFLOXACIN SHOULD BE AVOIDED IN PATIENTS WITH KNOWN PROLONGATION OF THE QTc INTERVAL, PATIENTS WITH UNCORRECTED HYPOKALEMIA, AND PATIENTS RECEIVING CLASS IA (E.G. QUINIDINE, PROCAINAMIDE) OR CLASS III (E.G. AMIODARONE, SOTALOL) ANTIARRHYTHMIC AGENTS.Ruptures of the shoulder, hand, and Achilles tendons that required surgical repair or resulted in prolonged disability have been reported in patients receiving quinolones. Tendon rupture can occur during or after therapy with quinolones. Quinolones may cause central nervous system (CNS) events including nervousness, agitation, insomnia, anxiety, nightmares, or paranoia.As with other quinolones, disturbances of blood glucose, including symptomatic hyper- and hypoglycemia, have been reported, usually in diabetic patients receiving concomitant treatment with an oral hypoglycemic (e. g., glyburide) or with insulin. In these patients, the monitoring of blood glucose is recommended.
Description (monograph translate from a German posting so it may not be as complete as the other monographs) Fleroxacin Application - damage mechanism - side effects - reciprocal effects - contraindications - commercial preparations - legal Fleroxacin Application Fleroxacin can with infections of the urinary passages, with which Gonorrhoe are used and with infections of the Darmtraktes. Furthermore Fleroxacin can be used with the acute aggravation of chronic bronchitis. Damage mechanism Fleroxacin belongs to the group of active substances of the Gyrasehemmer . The damage mechanism of all Fluorochinolone is identical. They bind Gyrase to the Topoisomerase II, also mentioned, whereby this is restrained. The Topoisomerase II is an enzyme, whose task is it to bring the bacterial DNA into a form so that this fits in the bacteria cell. The DNA is folded for this purpose of the Topoisomerase II and called spiral twisted, this procedure also Supercoiling. The result is that those finds approx. 1 mm long DNA in the only about 0.1 mm large bacteria cell place. From the connection of the Fluorochinolone to the Topoisomerase II result stable complexes, which release a multiplicity of enzymatic reactions, which lead last end to cell death. Side effects The most frequent side effects, which are observed with the treatment with Gyrasehemmern, are unwanted reactions at the gastro-intestinal tract. It can come to loss of appetite, to nausea and vomiting. In addition blockages, in addition, Durchfaelle can occur. Further side effects can concern the nervous system, whereby it can come here to a increased exciting barness, to unrest and sleep disturbances and even to convulsions. Additionally confusion, behaviourness and the inclination to hallucinations are observed. Before the income of Gyrasehemmern it should be also always referred to that on a retarded reactivity must be counted, which problems with the participation in the traffic give can. Furthermore side effects at the skin can occur, which can be it shown e.g. in the form of Exanthemen or skin excursions and as photosensitizations. By photosensitizations a increased sensitivity of the skin with inclination to inflammations and excursions are understood, which arise at skin areas after exposure to the sun. Temporarily it can come to an increase of the liver enzymes in the blood, which a reference to a damage of the liver cells can give. In addition also changes of the blood picture can occur, whereby it can come here to a degradation of the number of blood cells. Additionally it applies for Fleroxacin that it can come with women occasionally to Vaginalmykosen with Candida albicans. Reciprocal effects Mineral Antazida, iron, zinc and Multivitaminpraeparate: The mentioned substances and medicaments can decrease the admission of the Gyrasehemmer from the intestine. Theophyllin and coffein: The Gyrasehemmer can retard the dismantling of Theophyllin and coffein. Thus the concentration of the specified substances in the blood can increase, which can particularly have dangerous effects in view to Theophyllin. Ciclosporin: If Gyrasehemmer and Ciclosporin are together given, the toxic effects of Ciclosporin can strengthen. Fenbuten: With combination of Gyrasehemmern and Fenbuten, the danger of convulsions can increase. Oral Antikoagulanzien: The effect of oral Antikoagulanzien can strengthen in presence of Gyrasehemmern. Glibenclamid: The danger of a Hypoglykaemie, thus a Unterzuckerung, is strengthened with the simultaneous gift with Gyrasehemmern. Sucralfat: The admission of Fleroxacin is decreased by the simultaneous gift of Sucralfat over the intestine up to a third. Contraindications On illnesses of the central nervous system, e.g. epilepsy, disturbances the bloods Liquor barrier etc. may not do, Gyrasehemmer are given. Furthermore a disturbed liver function and a before-damaged kidney represent contraindications for the treatment with Gyrasehemmern. With hypersensitivenesses against Gyrasehemmer the substances may not likewise be given. The use of Gyrasehemmern with pregnant women women, satisfying mothers and children and young people under 18 years may not take place. The reason for these contraindications is that the Gyrasehemmer stands in suspicion, to cause itself with in growth body present durable joint cartilage damage. Commercial preparations Quinodis® 200 mg and Quinodis® 400 mg film tablets of the company Gruenenthal contain Fleroxacin.
|
|
 |
|
 |
|
|
|
|